marinuspharma.com (MRNS) - Uzoq muddatli majburiyatlarning kapitalga nisbati

Marinus Pharmaceuticals - MRNS emitenti grafik logotipi

Marinus Pharmaceuticals (MRNS) epilepsiyaning og'ir shakllarini davolash uchun patentlangan dori vositalarini ishlab chiqadi, bunda kasallikning surunkali tabiati barqaror talab va yuqori marjalarni ta'minlaydi. Kompaniyaga tegishli daromadlar shifoxonalarga innovatsion agentlarni yetkazib berish va sug'urta to'lovlariga tayanadi. GURU.Markets platformasida aksiyalarning vizuallashtirilgan narx harakati, qaysiki hozirda 0.00 darajasida turibdi, neyromarkazlar orqali mijozlar bazasining faol global kengayish davrini tasdiqlaydi.

Marinus Pharmaceuticals Inc (MRNS): Uzoq muddatli qarzning o'z kapitaliga nisbati 04.07.2022dan 22.02.2025gacha

Marinus Pharmaceuticals kompaniyasining tahliliy kesimlari

- joriy narx va aksiyalarning prognoz qilingan qiymati:
Aksiya kursi Marinus Pharmaceuticals Inc|MRNS - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi ko'rsatkichlari:
Bozor qiymati Marinus Pharmaceuticals, Inc.|MRNS - Kompaniyani butunlay sotib olishdagi haqiqiy narx
- xususiy kapitalning balans qiymati ko'rsatkichlari:
Bitta aksiya hisobiga balans qiymati Marinus Pharmaceuticals|MRNS - Kompaniyaning balans qiymati|Balans qiymatiga nisbatan bozor qiymati marinuspharma.com|MRNS - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning kapitalga nisbati Marinus Pharmaceuticals|MRNS - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning o'z kapitaliga nisbati marinuspharma.com|MRNS - Kompaniyaning jamlangan qarzlari|Balans kapitallashuviga qarzlar Marinus Pharmaceuticals, Inc.|MRNS - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli kredit va qarzlari Marinus Pharmaceuticals|Oraliq qoplama koeffitsiyenti marinuspharma.com
- sof foyda va baholash koeffitsiyentlari ma'lumotlari:
MRNS - Kompaniyaning sof foydasi
Kompaniyaning jamlanma tahlili:MRNS, Marinus Pharmaceuticals Inc
Marinus Pharmaceuticals, Inc. original mahsuloti

Marinus Pharmaceuticals (MRNS) moliyaviy barqarorligini baholash uning qarz kapitali tuzilmasini tahlil qilishni talab qiladi. Ushbu ko'rsatkich uzoq muddatli majburiyatlarning kapitalga nisbatini o'lchab, biznesning bir yildan ortiq muddatga tashqi moliyalashtirishga qanchalik bog'liqligini aniqlaydi. Uzoq muddatli qarz yuklamasi grafigini tahlil qilish orqali investor haddan tashqari leveraj xavfini aniqlaydi. Epilepsiya dori vositasining savdolaridagi joriy o'sish ushbu majburiyatlarni xizmat ko'rsatish uchun pul oqimini yaratmoqda. Bu kompaniyaning barqaror rivojlanishi davrida qarz risklarini kamaytiradi.

Raqobatdosh kompaniyalar tahlili

Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi BIIB (Biogen Inc)|Uzoq muddatli qarzning kapitalga nisbati NBIX|RGC - Uzoq muddatli majburiyatlarning kapitalga nisbati|Axsome Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati acadia-pharm.com ACAD|XENE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti VKTX (Viking Therapeutics Inc)|Supernus Pharma (SUPN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Catalyst Corp (CPRX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Denali Therapeutics|Uzoq muddatli qarzning o'z kapitaliga nisbati harmonybiosciences.com (HRMY)|Uzoq muddatli qarzning kapitalga nisbati BHVN|Uzoq muddatli qarzning kapitalga nisbati Amylyx Pharmaceuticals Inc (AMLX)|Uzoq muddatli qarzning o'z kapitaliga nisbati Trevi Pharma TRVI|Uzoq muddatli qarzning kapitalga koeffitsiyenti PRAX|Anavex Life Sciences - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati ceribell.com CBLL|Prothena Corp (PRTA) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi ALEC|Uzoq muddatli qarzning o'z kapitaliga nisbati ANNX|Uzoq muddatli qarzning kapitalga nisbati Omeros Corp.|Uzoq muddatli qarzning o'z kapitaliga nisbati Neurogene Inc. (NGNE)|Uzoq muddatli qarzdorlikning kapitalga nisbati acimmune.com|Voyager Therapeutics, Inc. - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli qarzning kapitalga koeffitsiyenti NMRA|SCLX - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati TVGN|ACOG: Uzoq muddatli qarzning kapitalga nisbati|cogrx.com - Uzoq muddatli qarzning kapitalga koeffitsiyenti|IKT (Inhibikase Therapeutics, Inc.) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Cassava Sciences Inc|Uzoq muddatli qarzning o'z kapitaliga nisbati Assertio Holdings, Inc. (ASRT)|COYA (coyatherapeutics.com) - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Vistagen VTGN|OVID - Uzoq muddatli qarzning o'z kapitaliga nisbati|Acumen Pharmaceuticals, Inc. - Uzoq muddatli qarzning kapitalga nisbati|CRVO - Uzoq muddatli qarzning kapitalga nisbati|ATHE: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Clene|PEPG (PepGen Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati jupiterneurosciences.com JUNS|Uzoq muddatli qarzning o'z kapitaliga nisbati RLMD (Relmada Therapeutics, Inc.)|Uzoq muddatli qarzning kapitalga nisbati Annovis Bio Inc (ANVS)|Grace Therapeutics - Uzoq muddatli qarzning o'z kapitaliga nisbati|Uzoq muddatli kreditlarning kapitalga nisbati AIFF (Firefly Neuro)|ANEW Medical, Inc. - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzdorlikning kapitalga nisbati NeuroSense Therapeutics NRSN|RVPH: Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati MetaVia|NRXS (NeurAxis, Inc) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning kapitalga nisbati Helius Medical Technologies Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Passage Bio, Inc. (PASG)|Uzoq muddatli qarzning o'z kapitaliga nisbati NEUP (bionomics.com.au)|Uzoq muddatli qarzning o'z kapitaliga nisbati Minerva Neurosciences, Inc. NERV|Uzoq muddatli qarzdorlikning kapitalga nisbati Athira Pharma Inc (ATHA)|ADXN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Alzamend Neuro, Inc. (ALZN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|cyclerion.com (CYCN) - Uzoq muddatli qarzning o'z kapitaliga nisbati|Protagenic Therapeutics, Inc. - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Pasithea Therapeutics Corp|Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi CRGT (Cortigent Medical)|Uzoq muddatli qarzning o'z kapitaliga nisbati Avenue Therapeutics, Inc (ATXI)|Uzoq muddatli qarzdorlikning kapitalga nisbati BrainStorm Cell Therapeutics Inc.|Uzoq muddatli qarzning o'z kapitaliga nisbati Cara Therapeutics, Inc. CARA|CHRO: Uzoq muddatli qarzning kapitalga nisbati ko'rsatkichi|Eliem - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli majburiyatlarning kapitalga nisbati Intra-Cellular Therapies|LBPH (Longboard Pharma) - Uzoq muddatli qarzning o'z kapitaliga nisbati|NKGen Biotech Corp (NKGN) - Uzoq muddatli qarzning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati NeuroBo Pharmaceuticals|SAGE: Uzoq muddatli qarzning kapitalga koeffitsiyenti|Uzoq muddatli qarzning o'z kapitaliga nisbati Synaptogenix (SNPX)|TRVN - Uzoq muddatli majburiyatlarning kapitalga nisbati|Uzoq muddatli qarzning o'z kapitaliga nisbati Vigil Neuroscience, Inc. VIGL|WENA - Uzoq muddatli qarzning o'z kapitaliga nisbati|Cerevel Therapeutics - Uzoq muddatli qarzning kapitalga nisbati